市場調査レポート

冠動脈ステント市場(ベアメタルステント、薬剤溶出ステント、バイオアブソーバブルステント)−世界の業界分析、市場規模、シェア、成長、動向および予測

Coronary Stents Market (Bare Metal Stents, Drug Eluting Stents and Bio-absorbable Stents) - Global Industry Analysis, Size, Share, Pipeline Overview, Growth, Trends and Forecast, 2013 - 2019

発行 Transparency Market Research 商品コード 302449
出版日 ページ情報 英文 100 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=104.18円で換算しております。
Back to Top
冠動脈ステント市場(ベアメタルステント、薬剤溶出ステント、バイオアブソーバブルステント)−世界の業界分析、市場規模、シェア、成長、動向および予測 Coronary Stents Market (Bare Metal Stents, Drug Eluting Stents and Bio-absorbable Stents) - Global Industry Analysis, Size, Share, Pipeline Overview, Growth, Trends and Forecast, 2013 - 2019
出版日: 2014年05月08日 ページ情報: 英文 100 Pages
概要

当レポートでは、世界の冠動脈ステント市場について調査し、市場の概要と2013〜2019年の予測、地域別動向、参入企業のプロファイルをまとめ、概略下記の構成で取り上げております。

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 世界の冠動脈ステント市場概要

  • イントロダクション
  • 市場促進因子
    • 冠動脈疾患の罹患率上昇
    • 世界的な肥満率の上昇
    • 高齢人口
  • 市場阻害因子
    • 製品コストの高さ
    • 効率的な償還システムの不足
    • ステント内および遅発性再狭窄および血栓症のハイリスク
  • 市場の機会
    • 治験における新たな技術が患者プールの様々なアンメットニーズを解決
    • アジア太平洋地域、ラテンアメリカ、アフリカなどの新興市場における高い成長機会
  • ポーターズファイブフォース分析
  • 市場の魅力度分析
  • 市場シェア分析

第4章 製品別市場

  • 概要
  • ベアメタルステント
  • 薬剤溶出ステント
  • バイオアブソーバブルステント

第5章 パイプライン概要

  • 概要
  • CORACTO
  • EXCELLA IIおよびEXCELLA BD
  • DESolve NxおよびDESolve FIM
  • ZoMaxx I and ZoMaxx II
  • ABSORB STEMI
  • BioFreedom
  • TAXUS PERSEUS
  • BioNIR

第6章 地域別市場

  • 概要
  • 北米
  • 欧州
  • アジア太平洋地域
  • その他

第7章 提言

第8章 企業プロファイル

  • Abbott Laboratories, Inc.
  • amg International GmbH
  • B. Braun Melsungen AG
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • C. R. Bard, Inc.
  • Cook Medical, Inc.
  • Johnson & Johnson
  • Medtronic, Inc.
  • MicroPort Scientific Corporation
  • STENTYS SA
  • テルモ株式会社

図表

目次

This report studies the current as well as future prospects of the coronary stents market globally. The market for coronary stents is categorized into three major segments, namely, bare metal stents (BMS), drug eluting stents (DES) and bio-absorbable stents. Each of the market segments has been extensively analyzed on the basis of their commercial existence, efficacy, sales revenue and geographic presence. The market size and forecast in terms of USD million for each product type has been provided for the period 2011 to 2019. The report also provides compounded annual growth rate (CAGR %) for each market segment for the forecast period 2013 to 2019, considering 2012 as the base year.

The global coronary stents market has been categorized into four geographical regions - North America, Europe, Asia-Pacific, and Rest of the World (RoW). The market sizes and forecasts for each of these regions have been provided for the period 2011 to 2019 along with CAGR (%) for the forecast period 2013 to 2019. The research study also incorporates the competitive scenario in these regions. A detailed qualitative analysis of the factors responsible for driving and restraining growth of the global coronary stents market and future opportunities has been provided in the market overview section. This section of the report also deals with market attractiveness analysis, Porter's five forces analysis and key players' market share analysis in 2012 for the global coronary stents market.

A list of recommendations has been provided for new entrants as well as existing market players to help them establish a strong presence in the market and increase their market share. The report also comprises a section on pipeline overview for this market that includes qualitative analysis for various coronary stents currently under phase II, III & IV clinical trials, which are expected to be launched during the forecast period.

The report also profiles major players of the global coronary stents market on the basis of various attributes such as company overview, financial overview, product portfolio, business strategies and recent developments. The major players profiled in this report include Abbott Laboratories, Inc., Boston Scientific Corporation, Medtronic, Inc., Johnson & Johnson, Terumo Corporation, B. Braun Melsungen AG, and C. R. Bard, Inc., Cook Medical, Inc., amg International GmbH, Biotronik SE & Co. KG, Stentys SA and MicroPort Scientific Corporation.

The global coronary stents market is segmented as follows:

Coronary Stents Market, by Product Type

  • Bare Metal Stents
  • Drug Eluting Stents
  • Bio-absorbable Stents

Coronary Stents Market, by Geography

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World (RoW)

Table of Contents

Chapter 1 - Introduction

  • 1.1. Report Description
  • 1.2. Market Segmentation
  • 1.3. Research Methodology

Chapter 2 - Executive Summary

  • 2.1. Market Snapshot: Global Coronary Stents Market
  • 2.2. Comparative Analysis: Global Coronary Stents Market, by Geography, 2012 & 2019 (Value %)

Chapter 3 - Global Coronary Stents Market Overview

  • 3.1. Introduction
  • 3.2. Market Drivers
    • 3.2.1. Increasing Prevalence of Coronary Artery Diseases (CADs)
    • 3.2.2. Rise in Global Obesity Rates
    • 3.2.3. Aging Population
    • 3.2.4. Increasing Uptake of Technologically Advanced Coronary Stents like Bio-absorbable Stents
  • 3.3. Market Restraints
    • 3.3.1. High Product Cost
    • 3.3.2. Lack of Efficient Reimbursement System
    • 3.3.3. High Risk of In-stent and Late-stent Restenosis and Thrombosis
  • 3.4. Market Opportunities
    • 3.4.1. Novel Technologies in Clinical Trials will Address Various Unmet Needs of the Patient Pool
    • 3.4.2. High Growth Opportunities in the Emerging Markets of APAC, LATAM and Africa
  • 3.5. Porter's Five Forces Analysis: Global Coronary Stents Market
    • 3.5.1. Bargaining Power of Suppliers
    • 3.5.2. Bargaining Power of Buyers
    • 3.5.3. Threat of Substitutes
    • 3.5.4. Threat of New Entrants
    • 3.5.5. Competitive Rivalry
  • 3.6. Market Attractiveness Analysis: Global Coronary Stents Market, by Geography
  • 3.7. Competitive Landscape
    • 3.7.1. Market Share Analysis: Global Coronary Stents Market, 2012 (Value %)

Chapter 4 - Global Coronary Stents Market, by Product Type

  • 4.1. Overview
    • 4.1.1. Coronary Stents: Key Brands by Manufacturer
    • 4.1.2. Global Coronary Stents Market Revenue, by Product Type, 2011 - 2019 (USD Million)
    • 4.1.3. Comparative Analysis: Global Coronary Stents Market, by Product Type, 2012 & 2019 (Value %)
  • 4.2. Bare Metal Stents
    • 4.2.1. Bare Metal Stents: Key Brands by Manufacturer
    • 4.2.2. Global Bare Metal Stents Market Revenue, 2011 - 2019 (USD Million)
  • 4.3. Drug Eluting Stents
    • 4.3.1. Drug Eluting Stents: Key Brands by Manufacturer
    • 4.3.2. Global Drug Eluting Stents Market Revenue, 2011 - 2019 (USD Million)
  • 4.4. Bio-absorbable Stents
    • 4.4.1. Bio-absorbable Stents: Key Brands by Manufacturer
    • 4.4.2. Global Bio-absorbable Stents Market Revenue, 2011 - 2019 (USD Million)

Chapter 5 - Global Coronary Stents Market: Pipeline Overview

  • 5.1. Overview
  • 5.2. CORACTO
  • 5.3. EXCELLA II and EXCELLA BD
  • 5.4. DESolve Nx and DESolve FIM
  • 5.5. ZoMaxx I and ZoMaxx II
  • 5.6. ABSORB STEMI
  • 5.7. BioFreedom
  • 5.8. TAXUS PERSEUS
  • 5.9. BioNIR

Chapter 6 - Global Coronary Stents Market, by Geography

  • 6.1 Overview
    • 6.1.1 Global Coronary Stents Market Revenue, by Geography, 2011 - 2019 (USD Million)
  • 6.2 North America
    • 6.2.1 North America Coronary Stents Market Revenue, 2011 - 2019 (USD Million)
  • 6.3 Europe
    • 6.3.1 Europe Coronary Stents Market Revenue, 2011 - 2019 (USD Million)
  • 6.4 Asia-Pacific
    • 6.4.1 Asia-Pacific Coronary Stents Market Revenue, 2011 - 2019 (USD Million)
  • 6.5 Rest of the World (RoW)
    • 6.5.1 RoW Coronary Stents Market Revenue, 2011 - 2019 (USD Million)

Chapter 7 - Recommendations

  • 7.1. Investing in Research and Development of Technologically Advanced Products with Additional Benefits
  • 7.2. Targeting Emerging Markets such as India, China, Brazil, Mexico, Russia and South Africa
  • 7.3. Emphasis on Price Control

Chapter 8 - Company Profiles

  • 8.1. Abbott Laboratories, Inc.
    • 8.1.1. Company Overview
    • 8.1.2. Financial Overview
    • 8.1.3. Product Portfolio
    • 8.1.4. Business Strategies
    • 8.1.5. Recent Developments
  • 8.2. amg International GmbH
    • 8.2.1. Company Overview
    • 8.2.2. Financial Overview
    • 8.2.3. Product Portfolio
    • 8.2.4. Business Strategies
    • 8.2.5. Recent Developments
  • 8.3. B. Braun Melsungen AG
    • 8.3.1. Company Overview
    • 8.3.2. Financial Overview
    • 8.3.3. Product Portfolio
    • 8.3.4. Business Strategies
    • 8.3.5. Recent Developments
  • 8.4. Biotronik SE & Co. KG
    • 8.4.1. Company Overview
    • 8.4.2. Financial Overview
    • 8.4.3. Product Portfolio
    • 8.4.4. Business Strategies
    • 8.4.5. Recent Developments
  • 8.5. Boston Scientific Corporation
    • 8.5.1. Company Overview
    • 8.5.2. Financial Overview
    • 8.5.3. Product Portfolio
    • 8.5.4. Business Strategies
    • 8.5.5. Recent Developments
  • 8.6. C. R. Bard, Inc.
    • 8.6.1. Company Overview
    • 8.6.2. Financial Overview
    • 8.6.3. Product Portfolio
    • 8.6.4. Business Strategies
    • 8.6.5. Recent Developments
  • 8.7. Cook Medical, Inc.
    • 8.7.1. Company Overview
    • 8.7.2. Financial Overview
    • 8.7.3. Product Portfolio
    • 8.7.4. Business Strategies
    • 8.7.5. Recent Developments
  • 8.8. Johnson & Johnson
    • 8.8.1. Company Overview
    • 8.8.2. Financial Overview
    • 8.8.3. Product Portfolio
    • 8.8.4. Business Strategies
    • 8.8.5. Recent Developments
  • 8.9. Medtronic, Inc.
    • 8.9.1. Company Overview
    • 8.9.2. Financial Overview
    • 8.9.3. Product Portfolio
    • 8.9.4. Business Strategies
    • 8.9.5. Recent Developments
  • 8.10. MicroPort Scientific Corporation
    • 8.10.1. Company Overview
    • 8.10.2. Financial Overview
    • 8.10.3. Product Portfolio
    • 8.10.4. Business Strategies
    • 8.10.5. Recent Developments
  • 8.11. STENTYS SA
    • 8.11.1. Company Overview
    • 8.11.2. Financial Overview
    • 8.11.3. Product Portfolio
    • 8.11.4. Business Strategies
    • 8.11.5. Recent Developments
  • 8.12. Terumo Corporation
    • 8.12.1. Company Overview
    • 8.12.2. Financial Overview
    • 8.12.3. Product Portfolio
    • 8.12.4. Business Strategies
    • 8.12.5. Recent Developments

List of Figures

  • FIG. 1: Coronary Stents: Market Segmentation
  • FIG. 2: Global Coronary Stents Market, by Product Type, 2012 (USD Million)
  • FIG. 3: Comparative Analysis: Global Coronary Stents Market, by Geography, 2012 & 2019 (Value %)
  • FIG. 4: Porter's Five Forces Analysis: Global Coronary Stents Market
  • FIG. 5: Market Attractiveness Analysis: Global Coronary Stents Market, by Geography
  • FIG. 6: Market Share by Key Players: Global Coronary Stents Market, 2012 (Value %)
  • FIG. 7: Comparative Analysis: Global Coronary Stents Market, by Product Type, 2012 & 2019 (Value %)
  • FIG. 8: Global Bare Metal Stents Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 9: Global Drug Eluting Stents Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 10: Global Bio-absorbable Stents Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 11: North America Coronary Stents Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 12: Europe Coronary Stents Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 13: Asia-Pacific Coronary Stents Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 14: RoW Coronary Stents Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 15: Abbott Laboratories, Inc.: Annual Revenue, 2010 - 2012 (USD Million)
  • FIG. 16: B. Braun Melsungen AG: Annual Revenue, 2010 - 2012 (USD Million)
  • FIG. 17: Boston Scientific Corporation: Annual Revenue, 2010 - 2012 (USD Million)
  • FIG. 18: C. R. Bard, Inc.: Annual Revenue, 2010 - 2012 (USD Million)
  • FIG. 19: Johnson & Johnson: Annual Revenue, 2010 - 2012 (USD Million)
  • FIG. 20: Medtronic, Inc.: Annual Revenue, 2010 - 2012 (USD Million)
  • FIG. 21: MicroPort Scientific Corporation: Annual Revenue, 2010 - 2012 (USD Million)
  • FIG. 22: STENTYS SA: Annual Revenue, 2010 - 2012 (USD Million)
  • FIG. 23: Terumo Corporation: Annual Revenue, 2010 - 2012 (USD Million)

List of Tables

  • TABLE 1: Market Snapshot: Global Coronary Stents Market
  • TABLE 2: Coronary Stents: Key Brands by Manufacturer
  • TABLE 3: Global Coronary Stents Market Revenue, by Product Type, 2011 - 2019 (USD Million)
  • TABLE 4: Bare Metal Stents: Key Brands by Manufacturer
  • TABLE 5: Drug Eluting Stents: Key Brands by Manufacturer
  • TABLE 6: Bio-absorbable Stents: Key Brands by Manufacturer
  • TABLE 7: Global Coronary Stents Market Revenue, by Geography, 2011 - 2019 (USD Million)
Back to Top